Quest Diagnostics, Inc.

NYSE:DGX   3:59:58 PM EDT
+2.31 (+1.62%)
4:00:00 PM EDT: $145.41 +0.06 (+0.04%)
Other Pre-Announcement

Quest Diagnostics Exec Says Rise in COVID-19 Testing To Some Extent Due To Delta Variant: Conf Call

Published: 07/22/2021 15:19 GMT
Quest Diagnostics, Inc. (DGX) - Quest Diagnostics Executive Says in Recent Weeks, Have Seen Covid-19 Pcr Testing Volumes Stabilize and Increase Modestly: Conf Call.
Quest Diagnostics Executive Says Increase in Covid-19 Testing is to Some Extent Due to Emergence of Delta Variant: Conf Call.
Quest Diagnostics Executive Says Lower End of FY Outlook Assumes at Least 20,000 Covid-19 Molecular Tests per Day in Second Half of 2021: Conf Call.